NSETrading Window28 Sept 2026 · 28 Sept 2026, 11:24 am

Trading Window

Torrent Pharmaceuticals Limited · TORNTPHARM

✦ AI Summary

Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in securities of the Company by Designated Persons stands closed from 1st October, 2026 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th September, 2026 to the Stock Exchanges.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

TORNTPHARM_28092026112359_SE_Intimation_Trading_window_closureQ2.pdf

pdf

Download →
View document text
28th September, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Intimation of the Closure of Trading Window as per Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company ('Code') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st October, 2026 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th September, 2026 to the Stock Exchanges. Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com